Skip to main content
Clinical Trials/NCT06859619
NCT06859619Not yet recruitingNot Applicable

Seroprevalence of Zoonotic and Arboviral Emerging Infections in Exposed Agents from the City of Montpellier: a Transversal Study.

University Hospital, Montpellier1 site in 1 country183 target enrollmentStarted: March 3, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
183
Locations
1
Primary Endpoint
Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Leishmaniasis,

Study Overview

Brief Summary

Zoonoses and arboviroses refer to a group of diseases transmitted from animals to humans, either directly or indirectly (via mosquitoes, ticks or contact with contaminated environments). Most of these diseases are found in certain tropical zones, but global warming and increased international trade are modifying their geographical distribution, with a gradual trend towards temperate regions. A number of these pathogens have already been detected in Occitania, including dengue fever, West Nile, leishmaniasis and Q fever. Given the region's high mosquito population and favorable climatic conditions, other zoonoses have a strong potential to appear in the region, or may already be circulating at a low level. The study focuses on 18 pathogens selected for their potential to emerge and establish themselves in the Occitanie region: Leishmaniasis, Leptospirosis, Brucellosis, Q fever, Rickettsiosis, Tularemia, Psittacosis, Lyme disease, Tick-borne encephalitis, Hantavirus, Hepatitis E virus, Dengue virus, Zika virus, Chikungunya virus, West-Nile virus, Usutu virus, Toscana virus, Crimean-Congo haemorrhagic fever virus.

The aim of the study is to find out whether patients have antibodies against these infectious agents, which would indicate that they have been exposed to them in the past, even in the absence of symptoms.

Describing the circulation of these pathogens will enable to implement appropriate public health measures to avoid the risk of epidemics (mosquito control, informing professionals, etc.), as well as to assess the risk incurred in the workplace and have this risk recognized by the healthcare system.

Detailed Description

Current environmental changes are influencing the epidemiology of zoonoses, which account for over 75% of emerging infections, with the Mediterranean region being a high-risk area. The proposed study focuses on occupational zoonoses, that is, those that can be contracted in the workplace, through direct contact with animals or exposure to their environment. Some of these zoonoses are recognized and compensable as occupational diseases (OD), while for others, the onus is on the employee to prove the origin of the contamination. The advantages of studying this population are threefold: i) to document occupational risk and improve management and prevention practices in this context, ii) to use this sentinel population - when many of these zoonoses are emerging - to anticipate risks for the less-exposed general population, iii) in the event of the discovery of a positive serology for an infectious agent considered non-circulating in the Occitanie region, to improve the management of symptomatic patients by raising awareness of differential diagnosis. For the purposes of this study, the zoonoses recognized as occupational diseases are: Mediterranean spotted fever, Lyme borreliosis, tularemia, Q fever, brucellosis, psittacosis, hepatitis E and leptospirosis. Although not recognized as occupational diseases, leishmaniasis, hantaviruses, dengue fever, zika, chikungunya, West Nile virus, Usutu, Toscana, Crimean-Congo hemorrhagic fever and tick-borne encephalitis are of particular interest to workers exposed to these diseases, and are also included in the study.

Few data are currently available on the actual rate of circulation of these pathogens in the population of occupationally exposed workers, and none in Occitanie. These outdoor workers also represent a sentinel population, due to their increased exposure, so obtaining precise seroprevalence data in these groups would enable the researchers to anticipate the emergence of these pathogens in the general population in the near future, and to diagnose them individually.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age 18 or over
  • •Consultant in an infectious diseases department
  • •Have given written consent to participate in the study
  • •Working for the City or Metropolis of Montpellier in the Zoo, Espaces Vert or Ecolothèque departments.

Exclusion Criteria

  • •- Pregnant and breast-feeding women
  • •Persons benefiting from legal protection measures (guardianship, curatorship, safeguard of justice)
  • •Participants who are not fluent in French and who do not have a support person capable of reading French.
  • •Persons unable to express their consent.
  • •Persons participating in another research project with an exclusion period still in progress.
  • •Persons not affiliated to a social security scheme or not benefiting from such a scheme.

Arms & Interventions

City of Montpellier employees working at the Zoo, the Ecolothèque and the Green Spaces Department

Experimental

City of Montpellier employees working at the Zoo, Ecolotheque or green spaces exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies) in the Occitanie region

Intervention: Peripheral venous blood sample (Other)

Outcomes

Primary Outcomes

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Leishmaniasis,

Time Frame: Baseline

prevalence (in percentage) of pathogen IgG positivity against : Leishmaniasis,

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Leptospirosis,

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Leptospirosis,

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Brucellosis

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Brucellosis

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Q fever

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Q fever

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Rickettsiosis

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Rickettsiosis,

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Tularemia

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Tularemia

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Psittacosis

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Psittacosis

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Lyme disease,

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Lyme disease,

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Tick-borne encephalitis

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Tick-borne encephalitis

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Hantavirus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Hantavirus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Hepatitis E virus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Hepatitis E virus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Dengue virus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Dengue virus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). Zika virus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Zika virus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Chikungunya virus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Chikungunya virus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). West-Nile virus,

Time Frame: Baseline

prevalence of pathogen IgG positivity against : West-Nile virus,

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies). usutu virus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Usutu virus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Toscana virus

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Toscana virus

Estimate seroprevalences of the zoonoses in populations exposed to wildlife by zoo staff and to various vectors (ticks, mosquitoes, sandflies).Crimean-Congo haemorrhagic fever virus.

Time Frame: Baseline

prevalence of pathogen IgG positivity against : Crimean-Congo haemorrhagic fever virus.

Secondary Outcomes

  • Determine the factors associated with seropositivity to these diseases. socio-demographic criteria(Baseline)
  • Determine the factors associated with seropositivity to these diseases. travel to endemic areas(Baseline)
  • Determine the factors associated with seropositivity to these diseases. occupational exposure(Baseline)
  • Determine the factors associated with seropositivity to these diseases. exposure in private activities(Baseline)
  • Determine the factors associated with seropositivity to these diseases. use of mosquito protection(Baseline)
  • Determine the factors associated with seropositivity to these diseases.history of transfusion or transplant(Baseline)
  • Determine the factors associated with seropositivity to these diseases. comparison of the linear models(Baseline)
  • Estimating vaccination coverage against leptospirosis in the workplace(Baseline)
  • Estimating vaccination coverage against rabies in the workplace(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Dengue virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Dengue virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Zika virus(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Zika virus(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Chikungunya virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Chikungunya virus(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. West-Nile virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. West-Nile virus(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Usutu virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Usutu virus(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Toscana virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Toscana virus(Baseline)
  • Determine the sensitivity of DBS (dried blood spot) serum neutralization for viral serologies. Crimean-Congo haemorrhagic fever virus(Baseline)
  • Determine the specificity of DBS (dried blood spot) serum neutralization for viral serologies. Crimean-Congo haemorrhagic fever virus(Baseline)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Serological Measurement of Montpellier... | Clinical Trial